financetom
Business
financetom
/
Business
/
Commercial real estate financier Walker & Dunlop beats Q2 sales, profit estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commercial real estate financier Walker & Dunlop beats Q2 sales, profit estimates
Aug 7, 2025 3:45 AM

Overview

* Walker & Dunlop ( WD ) Q2 rev grows 18% yr/yr, beating analyst expectations

* Adjusted EPS for Q2 beats consensus, despite adjusted EBITDA missing estimates

* Co's transaction volume rises 65%, driven by strong commercial real estate demand

Outlook

* Walker & Dunlop ( WD ) expects continued growth in Capital Markets as investment cycle gains momentum

* Company anticipates H2 origination fee and MSR income margins to be in line with Q2

Result Drivers

* TRANSACTION VOLUME - Total transaction volume grew 65% to $14 bln, driven by strong debt financing activity with Fannie Mae and Freddie Mac

* COMMERCIAL REAL ESTATE DEMAND - Rebounding demand for financing and capital deployment in commercial real estate market contributed to revenue growth

* SERVICING PORTFOLIO - Growth in servicing portfolio led by Fannie Mae loans, adding $1.7 bln of net loans in Q2 2025

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $319.20 $278.20

Revenue mln mln (3

Analysts

)

Q2 Beat $1.15 $0.72 (3

Adjusted Analysts

EPS )

Q2 EPS $0.99

Q2 Net $33.95

Income mln

Q2 Miss $76.81 $81.10

Adjusted mln mln (3

EBITDA Analysts

)

Q2 $18.62

Assets bln

Under

Manageme

nt

Q2 EBIT 15.0%

Margin

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the banks peer group is "buy."

* Wall Street's median 12-month price target for Walker & Dunlop Inc ( WD ) is $92.50, about 18.4% above its August 6 closing price of $75.48

* The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lucid to open orders for Gravity electric SUV next week
Lucid to open orders for Gravity electric SUV next week
Nov 3, 2024
Oct 29 (Reuters) - Electric-vehicle maker Lucid Group ( LCID ) said on Tuesday it will open orders for its Gravity SUV on Nov. 7, as it looks to drum up demand and attract a wider swathe of customers. The move comes on the heels of a successful fundraising round as Lucid looks to expand its product lineup to compete...
Pitney Bowes Makes Lance Rosenzweig Permanent CEO
Pitney Bowes Makes Lance Rosenzweig Permanent CEO
Nov 3, 2024
09:03 AM EDT, 10/29/2024 (MT Newswires) -- Pitney Bowes ( PBI ) said Tuesday it appointed Lance Rosenzweig permanent chief executive. Rosenzweig was the company's interim CEO. The company also announced the election of Milena Alberti-Perez as non-executive chair. She has been on the company's board since May 2023. Price: 7.22, Change: +0.01, Percent Change: +0.14 ...
Ford Motor's UK Workers to Walk Out as Labor Negotiations Fail; Shares Down Pre-Bell
Ford Motor's UK Workers to Walk Out as Labor Negotiations Fail; Shares Down Pre-Bell
Nov 3, 2024
09:08 AM EDT, 10/29/2024 (MT Newswires) -- Ford Motor ( F ) workers across the UK will strike starting Wednesday after labor negotiations broke down, British union Unite said Tuesday. Over 1,000 administrative staff will walk out for 24 hours, Unite said. The union cited Ford's lack of a permanent pay increase offer for the failed negotiations. Instead, the company...
Pfizer profits up on COVID treatment sales as it faces off with activist
Pfizer profits up on COVID treatment sales as it faces off with activist
Nov 3, 2024
* Paxlovid sales surge to $2.7 billion, beating expectations * Pfizer ( PFE ) raises annual revenue forecast for COVID products to $10.5 billion * Pfizer ( PFE ) management faces pressure from activist hedge fund Starboard Value * Pfizer ( PFE ) raises full-year profit forecast by 30 cents a share (Adds background on Starboard and analyst comment in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved